| Kristin E Sorce, PA C | |
|
3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Kristin E Sorce |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 26 Years |
| Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225061500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | PA00729 (Tennessee) | Secondary |
| 363A00000X | Physician Assistant | 729 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vanderbilt Wilson County Hospital | Lebanon, TN | Hospital |
| Vanderbilt University Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.
AppDynamics, Inc.™, the next-generation Application Performance Management (APM) company, today announced that it has closed its Series B round of financing, and had raised $11 million. The round is co-led by existing Series A investors Lightspeed Venture Partners and Greylock Partners, and will support the company's continued expansion as it takes advantage of market demand for next-generation application performance management (APM). To date, the company has received $16.5 million in venture funding.
New results from the Women's Health Initiative (WHI) confirm that the health risks of long-term use of combination (estrogen plus progestin) hormone therapy in healthy, postmenopausal women persist even a few years after stopping the drugs and clearly outweigh the benefits.
Every 40 seconds, a person dies from heart disease in the United States, making it the single leading cause of death in that country, as well as worldwide. But what if all those damaged hearts could be repaired with the flick of a switch? A $1 million international study led by the University of South Australia is hoping to do just that.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin E Sorce, PA C 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Kristin E Sorce, PA C 3601 The Vanderbilt Clinic, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.
AppDynamics, Inc.™, the next-generation Application Performance Management (APM) company, today announced that it has closed its Series B round of financing, and had raised $11 million. The round is co-led by existing Series A investors Lightspeed Venture Partners and Greylock Partners, and will support the company's continued expansion as it takes advantage of market demand for next-generation application performance management (APM). To date, the company has received $16.5 million in venture funding.
New results from the Women's Health Initiative (WHI) confirm that the health risks of long-term use of combination (estrogen plus progestin) hormone therapy in healthy, postmenopausal women persist even a few years after stopping the drugs and clearly outweigh the benefits.
Every 40 seconds, a person dies from heart disease in the United States, making it the single leading cause of death in that country, as well as worldwide. But what if all those damaged hearts could be repaired with the flick of a switch? A $1 million international study led by the University of South Australia is hoping to do just that.
› Verified 6 days ago